Influence of the dopaminergic system, CREB, and transcription factor-κB on cocaine neurotoxicity

Brazilian Journal of Medical and Biological Research

Volumn 46, Issue 11, 2013, Pages 909-915

  Planeta, C S ^b   Lepsch, L B ^a   Alves, R ^a   Scavone, C ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

Author keywords

Apoptosis; BDNF; Cocaine; CREB; Neurotoxicity; NF B

Indexed keywords

8 CHLORO 2, 3, 4, 5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; BRAIN DERIVED NEUROTROPHIC FACTOR; CASPASE 3; CASPASE 6; CASPASE 7; COCAINE; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; CYTOCHROME C; DOPAMINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIDOCAINE; MESSENGER RNA; PROTEIN BAX; PROTEIN BCL 2; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 2; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VANOXERINE;

APOPTOSIS; DNA FRAGMENTATION; DOPAMINERGIC SYSTEM; DRUG ABUSE; GENETIC TRANSCRIPTION; HUMAN; NERVE DEGENERATION; NEUROTOXICITY; NONHUMAN; OXIDATIVE STRESS; PC12 CELL; REVIEW;

EID: 84888406691     PISSN: 0100879X     EISSN: 1414431X     Source Type: Journal    
DOI: 10.1590/1414-431X20133379     Document Type: Review

References (90)

1. Wise RA, Bozarth MA. A psychomotor stimulant theory of addiction. Psychol Rev 1987; 94: 469-492, doi: 10.1037/ 0033-295X.94.4.469.
2. Robinson TE, Becker JB. Enduring changes in brain and behavior produced by chronic amphetamine administration: a review and evaluation of animal models of amphetamine psychosis. Brain Res 1986; 396: 157-198, doi: 10.1016/ 0165-0173(86)90002-0.
3. Leshner AI. Addiction is a brain disease, and it matters. Science 1997; 278: 45-47, doi: 10.1126/science.278.5335. 45.
4. Uhl GR, Grow RW. The burden of complex genetics in brain disorders. Arch Gen Psychiatry 2004; 61: 223-229, doi: 10.1001/archpsyc.61.3.223.
5. Nnadi CU, Mimiko OA, McCurtis HL, Cadet JL. Neuropsychiatric effects of cocaine use disorders. J Natl Med Assoc 2005; 97: 1504-1515.
6. Mittleman RE, Wetli CV. Death caused by recreational cocaine use. An update. JAMA 1984; 252: 1889-1893, doi: 10.1001/jama.1984.03350140035021.
7. Cregler LL, Mark H. Medical complications of cocaine abuse. N Engl J Med 1986; 315: 1495-1500, doi: 10.1056/ NEJM198612043152327.
8. Bates CK. Medical risks of cocaine use. West J Med 1988; 148: 440-444.
9. Wilson MC, Holbrook JM. Intravenous cocaine lethality in the rat. Pharmacol Res Commun 1978; 10: 243-256, doi: 10.1016/S0031-6989(78)80018-6.
10. Bozarth MA, Wise RA. Toxicity associated with long-term intravenous heroin and cocaine self-administration in the rat. JAMA 1985; 254: 81-83, doi: 10.1001/jama.1985. 03360010087032.
11. Ferri CP, Dunn J, Gossop M, Laranjeira R. Factors associated with adverse reactions to cocaine among a sample of long-term, high-dose users in São Paulo, Brazil. Addict Behav 2004; 29: 365-374, doi: 10.1016/j.addbeh. 2003.08.029.
12. Karch SB. Diphenhydramine toxicity: comparisons of postmortem findings in diphenhydramine-, cocaine-, and heroinrelated deaths. Am J Forensic Med Pathol 1998; 19: 143-147, doi: 10.1097/00000433-199806000-00008.
13. Karch SB, Stephens BS. When is cocaine the cause of death? Am J Forensic Med Pathol 1991; 12: 1-2, doi: 10.1097/00000433-199103000-00001.
14. Glauser J, Queen JR. An overview of non-cardiac cocaine toxicity. J Emerg Med 2007; 32: 181-186, doi: 10.1016/ j.jemermed.2006.05.044.
15. Dhuna A, Pascual-Leone A, Langendorf F. Chronic, habitual cocaine abuse and kindling-induced epilepsy: a case report. Epilepsia 1991; 32: 890-894, doi: 10.1111/j.1528-1157. 1991.tb05547.x.
16. Marshall W. Size control in dynamic organelles. Trends Cell Biol 2002; 12: 414-419, doi: 10.1016/S0962-8924(02) 02341-3.
17. Yuan C, Acosta D Jr. Cocaine-induced mitochondrial dysfunction in primary cultures of rat cardiomyocytes. Toxicology 1996; 112: 1-10, doi: 10.1016/0300-483X(96) 03341-0.
18. Powers JF, Alroy J, Shuster L. Hepatic morphologic and biochemical changes induced by subacute cocaine administration in mice. Toxicol Pathol 1992; 20: 61-70, doi: 10.1177/019262339202000108.
19. Carpenter G, Cohen S. 125I-labeled human epidermal growth factor. Binding, internalization, and degradation in human fibroblasts. J Cell Biol 1976; 71: 159-171, doi: 10.1083/jcb.71.1.159.
20. Ardila A, Rosselli M, Strumwasser S. Neuropsychological deficits in chronic cocaine abusers. Int J Neurosci 1991; 57: 73-79, doi: 10.3109/00207459109150348.
21. O'Malley S, Adamse M, Heaton RK, Gawin FH. Neuropsychological impairment in chronic cocaine abusers. Am J Drug Alcohol Abuse 1992; 18: 131-144, doi: 10.3109/ 00952999208992826.
22. Mittenberg W, Motta S. Effects of chronic cocaine abuse on memory and learning. Arch Clin Neuropsychol 1993; 8: 477-483.
23. Mayes LC. Genetics of childhood disorders: LV. Prenatal drug exposure. J Am Acad Child Adolesc Psychiatry 2003; 42: 1258-1261, doi: 10.1097/00004583-200310000-00019.
24. Arendt RE, Short EJ, Singer LT, Minnes S, Hewitt J, Flynn S, et al. Children prenatally exposed to cocaine: developmental outcomes and environmental risks at seven years of age. J Dev Behav Pediatr 2004; 25: 83-90, doi: 10.1097/ 00004703-200404000-00002.
25. Thompson BL, Levitt P, Stanwood GD. Prenatal cocaine exposure specifically alters spontaneous alternation behavior. Behav Brain Res 2005; 164: 107-116, doi: 10.1016/ j.bbr.2005.06.010.
26. Chasnoff IJ, Griffith DR. Cocaine: clinical studies of pregnancy and the newborn. Ann N Y Acad Sci 1989; 562: 260-266, doi: 10.1111/j.1749-6632.1989.tb21024.x.
27. Dow-Edwards DL. Long-term neurochemical and neurobehavioral consequences of cocaine use during pregnancy. Ann N Y Acad Sci 1989; 562: 280-289, doi: 10.1111/j.1749-6632.1989.tb21026.x.
28. Schenker S, Yang Y, Johnson RF, Downing JW, Schenken RS, Henderson GI, et al. The transfer of cocaine and its metabolites across the term human placenta. Clin Pharmacol Ther 1993; 53: 329-339, doi: 10.1038/clpt. 1993.29.
29. Wiggins RC, Rolsten C, Ruiz B, Davis CM. Pharmacokinetics of cocaine: basic studies of route, dosage, pregnancy and lactation. Neurotoxicology 1989; 10: 367-381.
30. Szeto HH. Kinetics of drug transfer to the fetus. Clin Obstet Gynecol 1993; 36: 246-254, doi: 10.1097/00003081-199306000-00006.
31. Handler A, Kistin N, Davis F, Ferre C. Cocaine use during pregnancy: perinatal outcomes. Am J Epidemiol 1991; 133: 818-825.
32. Silvestri JM, Long JM, Weese-Mayer DE, Barkov GA. Effect of prenatal cocaine on respiration, heart rate, and sudden infant death syndrome. Pediatr Pulmonol 1991; 11: 328-334, doi: 10.1002/ppul.1950110409.
33. Lester BM, Tronick EZ, LaGasse L, Seifer R, Bauer CR, Shankaran S, et al. The maternal lifestyle study: effects of substance exposure during pregnancy on neurodevelopmental outcome in 1-month-old infants. Pediatrics 2002; 110: 1182-1192, doi: 10.1542/peds.110.6.1182.
34. Harvey JA. Cocaine effects on the developing brain: current status. Neurosci Biobehav Rev 2004; 27: 751-764, doi: 10.1016/j.neubiorev.2003.11.006.
35. Singer LT, Minnes S, Short E, Arendt R, Farkas K, Lewis B, et al. Cognitive outcomes of preschool children with prenatal cocaine exposure. JAMA 2004; 291: 2448-2456, doi: 10.1001/jama.291.20.2448.
36. Johnson JE Jr, Weissman AD. Cocaine produces fine structural nuclear alterations in cultured neuroglioblastoma cells. Brain Res Bull 1988; 20: 39-47, doi: 10.1016/0361-9230(88)90007-X.
37. Zachor D, Cherkes JK, Fay CT, Ocrant I. Cocaine differentially inhibits neuronal differentiation and proliferation in vitro. J Clin Invest 1994; 93: 1179-1185, doi: 10.1172/ JCI117071.
38. Nassogne MC, Louahed J, Evrard P, Courtoy PJ. Cocaine induces apoptosis in cortical neurons of fetal mice. J Neurochem 1997; 68: 2442-2450, doi: 10.1046/j.1471-4159.1997.68062442.x.
39. Hu S, Cheeran MC, Sheng WS, Ni HT, Lokensgard JR, Peterson PK. Cocaine alters proliferation, migration, and differentiation of human fetal brain-derived neural precursor cells. J Pharmacol Exp Ther 2006; 318: 1280-1286, doi: 10.1124/jpet.106.103853.
40. Mayes LC. Developing brain and in utero cocaine exposure: effects on neural ontogeny. Dev Psychopathol 1999; 11: 685-714, doi: 10.1017/S0954579499002278.
41. Hope B, Kosofsky B, Hyman SE, Nestler EJ. Regulation of immediate early gene expression and AP-1 binding in the rat nucleus accumbens by chronic cocaine. Proc Natl Acad Sci U S A 1992; 89: 5764-5768, doi: 10.1073/pnas.89.13. 5764.
42. Ennulat DJ, Babb S, Cohen BM. Persistent reduction of immediate early gene mRNA in rat forebrain following single or multiple doses of cocaine. Brain Res Mol Brain Res 1994; 26: 106-112, doi: 10.1016/0169-328X(94)90080-9.
43. Mackler SA, Eberwine JH. The molecular biology of addictive drugs. Mol Neurobiol 1991; 5: 45-58, doi: 10.1007/BF02935612.
44. Montminy MR, Bilezikjian LM. Binding of a nuclear protein to the cyclic-AMP response element of the somatostatin gene. Nature 1987; 328: 175-178, doi: 10.1038/328175a0.
45. Shaywitz AJ, Greenberg ME. CREB: a stimulus-induced transcription factor activated by a diverse array of extracellular signals. Annu Rev Biochem 1999; 68: 821-861, doi: 10.1146/annurev.biochem.68.1.821.
46. Chrivia JC, Kwok RP, Lamb N, Hagiwara M, Montminy MR, Goodman RH. Phosphorylated CREB binds specifically to the nuclear protein CBP. Nature 1993; 365: 855-859, doi: 10.1038/365855a0.
47. Cardinaux JR, Notis JC, Zhang Q, Vo N, Craig JC, Fass DM, et al. Recruitment of CREB binding protein is sufficient for CREB-mediated gene activation. Mol Cell Biol 2000; 20: 1546-1552, doi: 10.1128/MCB.20.5.1546-1552.2000.
48. Nestler EJ, Hope BT, Widnell KL. Drug addiction: a model for the molecular basis of neural plasticity. Neuron 1993; 11: 995-1006, doi: 10.1016/0896-6273(93)90213-B.
49. Kobayashi M, Kawakami K. ATF-1CREB heterodimer is involved in constitutive expression of the housekeeping Na, K-ATPase alpha 1 subunit gene. Nucleic Acids Res 1995; 23: 2848-2855, doi: 10.1093/nar/23.15.2848.
50. Nestler EJ, Aghajanian GK. Molecular and cellular basis of addiction. Science 1997; 278: 58-63, doi: 10.1126/science. 278.5335.58.
51. Barkett M, Gilmore TD. Control of apoptosis by Rel/NFkappaB transcription factors. Oncogene 1999; 18: 6910-6924, doi: 10.1038/sj.onc.1203238.
52. Kaltschmidt C, Kaltschmidt B, Neumann H, Wekerle H, Baeuerle PA. Constitutive NF-kappa B activity in neurons. Mol Cell Biol 1994; 14: 3981-3992.
53. Hoffmann A, Baltimore D. Circuitry of nuclear factor kappaB signaling. Immunol Rev 2006; 210: 171-186, doi: 10.1111/ j.0105-2896.2006.00375.x.
54. Munhoz CD, Lepsch LB, Kawamoto EM, Malta MB, Lima LS, Avellar MC, et al. Chronic unpredictable stress exacerbates lipopolysaccharide-induced activation of nuclear factor-kappaB in the frontal cortex and hippocampus via glucocorticoid secretion. J Neurosci 2006; 26: 3813-3820, doi: 10.1523/JNEUROSCI.4398-05.2006.
55. Mattson MP, Meffert MK. Roles for NF-kappaB in nerve cell survival, plasticity, and disease. Cell Death Differ 2006; 13: 852-860, doi: 10.1038/sj.cdd.4401837.
56. Ghosh S, May MJ, Kopp EB. NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses. Annu Rev Immunol 1998; 16: 225-260, doi: 10.1146/ annurev.immunol.16.1.225.
57. Ghosh S, Karin M. Missing pieces in the NF-kappaB puzzle. Cell 2002; 109 (Suppl): S81-S96, doi: 10.1016/S0092-8674(02)00703-1.
58. Lepsch LB, Munhoz CD, Kawamoto EM, Yshii LM, Lima LS, Curi-Boaventura MF, et al. Cocaine induces cell death and activates the transcription nuclear factor kappa-B in PC12 cells. Mol Brain 2009; 2: 3-9, doi: 10.1186/1756-6606-2-3.
59. Cunha-Oliveira T, Rego AC, Morgadinho MT, Macedo T, Oliveira CR. Differential cytotoxic responses of PC12 cells chronically exposed to psychostimulants or to hydrogen peroxide. Toxicology 2006; 217: 54-62, doi: 10.1016/j.tox. 2005.08.022.
60. Dey S, Mactutus CF, Booze RM, Snow DM. Cocaine exposure in vitro induces apoptosis in fetal locus coeruleus neurons by altering the Bax/Bcl-2 ratio and through caspase-3 apoptotic signaling. Neuroscience 2007; 144: 509-521, doi: 10.1016/j.neuroscience.2006.09.047.
61. Dhillon NK, Williams R, Peng F, Tsai YJ, Dhillon S, Nicolay B, et al. Cocaine-mediated enhancement of virus replication in macrophages: implications for human immunodeficiency virus-associated dementia. J Neurovirol 2007; 13: 483-495, doi: 10.1080/13550280701528684.
62. Lee YW, Hennig B, Yao J, Toborek M. Methamphetamine induces AP-1 and NF-kappaB binding and transactivation in human brain endothelial cells. J Neurosci Res 2001; 66: 583-591, doi: 10.1002/jnr.1248.
63. Imam SZ, Duhart HM, Skinner JT, Ali SF. Cocaine induces a differential dose-dependent alteration in the expression profile of immediate early genes, transcription factors, and caspases in PC12 cells: a possible mechanism of neurotoxic damage in cocaine addiction. Ann N Y Acad Sci 2005; 1053: 482-490, doi: 10.1196/annals.1344.042.
64. Ang E, Chen J, Zagouras P, Magna H, Holland J, Schaeffer E, et al. Induction of nuclear factor-kappaB in nucleus accumbens by chronic cocaine administration. J Neurochem 2001; 79: 221-224, doi: 10.1046/j.1471-4159. 2001.00563.x.
65. Lezoualc'h F, Sagara Y, Holsboer F, Behl C. High constitutive NF-kappaB activity mediates resistance to oxidative stress in neuronal cells. J Neurosci 1998; 18: 3224-3232.
66. Barger SW, Horster D, Furukawa K, Goodman Y, Krieglstein J, Mattson MP. Tumor necrosis factors alpha and beta protect neurons against amyloid beta-peptide toxicity: evidence for involvement of a kappa B-binding factor and attenuation of peroxide and Ca2+ accumulation. Proc Natl Acad Sci U S A 1995; 92: 9328-9332, doi: 10.1073/pnas.92.20.9328.
67. Mattson MP, Culmsee C, Yu ZF. Apoptotic and antiapoptotic mechanisms in stroke. Cell Tissue Res 2000; 301: 173-187, doi: 10.1007/s004419900154.
68. Yuan C, Acosta D Jr. Effect of cocaine on mitochondrial electron transport chain evaluated in primary cultures of neonatal rat myocardial cells and in isolated mitochondrial preparations. Drug Chem Toxicol 2000; 23: 339-348, doi: 10.1081/DCT-100100119.
69. Clark KH, Wiley CA, Bradberry CW. Psychostimulant abuse and neuroinflammation: emerging evidence of their interconnection. Neurotox Res 2013; 23: 174-188, doi: 10.1007/ s12640-012-9334-7.
70. Mancuso M, Coppede F, Murri L, Siciliano G. Mitochondrial cascade hypothesis of Alzheimer's disease: myth or reality? Antioxid Redox Signal 2007; 9: 1631-1646, doi: 10.1089/ ars.2007.1761.
71. Sartorius U, Schmitz I, Krammer PH. Molecular mechanisms of death-receptor-mediated apoptosis. Chembiochem 2001; 2: 20-29, doi: 10.1002/1439-7633(20010105)2:1, 20::AID-CBIC20.3.0.CO;2-X.
72. Orlinick JR, Chao MV. TNF-related ligands and their receptors. Cell Signal 1998; 10: 543-551, doi: 10.1016/ S0898-6568(98)00018-7.
73. Michaelis EK. Molecular biology of glutamate receptors in the central nervous system and their role in excitotoxicity, oxidative stress and aging. Prog Neurobiol 1998; 54: 369-415, doi: 10.1016/S0301-0082(97)00055-5.
74. Haddad JJ. Oxygen-sensitive pro-inflammatory cytokines, apoptosis signaling and redox-responsive transcription factors in development and pathophysiology. Cytokines Cell Mol Ther 2002; 7: 1-14, doi: 10.1080/13684730216401.
75. Hutchins JB, Barger SW. Why neurons die: cell death in the nervous system. Anat Rec 1998; 253: 79-90, doi: 10.1002/ (SICI)1097-0185(199806)253:3,79::AID-AR4.3.0.CO;2-9.
76. Jemmerson R, Dubinsky JM, Brustovetsky N. Cytochrome C release from CNS mitochondria and potential for clinical intervention in apoptosis-mediated CNS diseases. Antioxid Redox Signal 2005; 7: 1158-1172, doi: 10.1089/ars. 2005.7.1158.
77. Kroemer G, Martin SJ. Caspase-independent cell death. Nat Med 2005; 11: 725-730, doi: 10.1038/nm1263.
78. Tsujimoto Y. Prevention of neuronal cell death by Bcl-2. Results Probl Cell Differ 1998; 24: 137-155, doi: 10.1007/ 978-3-540-69185-3_7.
79. Gross A, McDonnell JM, Korsmeyer SJ. BCL-2 family members and the mitochondria in apoptosis. Genes Dev 1999; 13: 1899-1911, doi: 10.1101/gad.13.15.1899.
80. Chen J, Simon RP, Nagayama T, Zhu R, Loeffert JE, Watkins SC, et al. Suppression of endogenous bcl-2 expression by antisense treatment exacerbates ischemic neuronal death. J Cereb Blood Flow Metab 2000; 20: 1033-1039, doi: 10.1097/00004647-200007000-00002.
81. Riccio A, Ahn S, Davenport CM, Blendy JA, Ginty DD. Mediation by a CREB family transcription factor of NGFdependent survival of sympathetic neurons. Science 1999; 286: 2358-2361, doi: 10.1126/science.286.5448.2358.
82. Mattson MP. Contributions of mitochondrial alterations, resulting from bad genes and a hostile environment, to the pathogenesis of Alzheimer's disease. Int Rev Neurobiol 2002; 53: 387-409, doi: 10.1016/S0074-7742(02)53014-2.
83. Huang EJ, Reichardt LF. Neurotrophins: roles in neuronal development and function. Annu Rev Neurosci 2001; 24: 677-736, doi: 10.1146/annurev.neuro.24.1.677.
84. Cunha-Oliveira T, Rego AC, Oliveira CR. Cellular and molecular mechanisms involved in the neurotoxicity of opioid and psychostimulant drugs. Brain Res Rev 2008; 58: 192-208, doi: 10.1016/j.brainresrev.2008.03.002.
85. Cunha-Oliveira T, Silva L, Silva AM, Moreno AJ, Oliveira CR, Santos MS. Mitochondrial complex I dysfunction induced by cocaine and cocaine plus morphine in brain and liver mitochondria. Toxicol Lett 2013; 219: 298-306, doi: 10.1016/j.toxlet.2013.03.025.
86. Xiao Y, He J, Gilbert RD, Zhang L. Cocaine induces apoptosis in fetal myocardial cells through a mitochondriadependent pathway. J Pharmacol Exp Ther 2000; 292: 8-14.
87. Lehrmann E, Oyler J, Vawter MP, Hyde TM, Kolachana B, Kleinman JE, et al. Transcriptional profiling in the human prefrontal cortex: evidence for two activational states associated with cocaine abuse. Pharmacogenomics J 2003; 3: 27-40, doi: 10.1038/sj.tpj.6500146.
88. Thomas K, Davies A. Neurotrophins: a ticket to ride for BDNF. Curr Biol 2005; 15: R262-R264, doi: 10.1016/ j.cub.2005.03.023.
89. Marini AM, Jiang X, Wu X, Tian F, Zhu D, Okagaki P, et al. Role of brain-derived neurotrophic factor and NF-kappaB in neuronal plasticity and survival: From genes to phenotype. Restor Neurol Neurosci 2004; 22: 121-130.
90. Fan L, Sawbridge D, George V, Teng L, Bailey A, Kitchen I, et al. Chronic cocaine-induced cardiac oxidative stress and mitogen-activated protein kinase activation: the role of Nox2 oxidase. J Pharmacol Exp Ther 2009; 328: 99-106, doi: 10.1124/jpet.108.145201.